These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20525999)

  • 1. Ezetimibe alone or in combination with simvastatin increases small dense low-density lipoproteins in healthy men: a randomized trial.
    Berneis K; Rizzo M; Berthold HK; Spinas GA; Krone W; Gouni-Berthold I
    Eur Heart J; 2010 Jul; 31(13):1633-9. PubMed ID: 20525999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trial.
    Olijhoek JK; Hajer GR; van der Graaf Y; Dallinga-Thie GM; Visseren FL
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):145-50. PubMed ID: 18670365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterolemia.
    Florentin M; Liberopoulos EN; Moutzouri E; Rizos CV; Tselepis AD; Elisaf MS
    Curr Med Res Opin; 2011 Mar; 27(3):685-92. PubMed ID: 21271793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ezetimibe and low density lipoprotein subfractions: an ongoing debate.
    Katsiki N; Athyros VG; Karagiannis A; Mikhailidis DP
    Curr Med Res Opin; 2011 Mar; 27(3):693-5. PubMed ID: 21275848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction.
    Robinson JG; Davidson MH
    Expert Rev Cardiovasc Ther; 2006 Jul; 4(4):461-76. PubMed ID: 16918265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals.
    Feldman T; Koren M; Insull W; McKenney J; Schrott H; Lewin A; Shah S; Sidisin M; Cho M; Kush D; Mitchel Y
    Am J Cardiol; 2004 Jun; 93(12):1481-6. PubMed ID: 15194017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluvastatin/fenofibrate vs. simvastatin/ezetimibe in patients with metabolic syndrome: different effects on LDL-profiles.
    Winkler K; Schewe T; Pütz G; Odünc N; Schäfer G; Siegel E; Geisen U; Abletshauser C; Hoffmann MM
    Eur J Clin Invest; 2009 Jun; 39(6):463-70. PubMed ID: 19397693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels.
    Pearson T; Ballantyne C; Sisk C; Shah A; Veltri E; Maccubbin D
    Am J Cardiol; 2007 Jun; 99(12):1706-1713. PubMed ID: 17560879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) study.
    Ballantyne CM; Abate N; Yuan Z; King TR; Palmisano J
    Am Heart J; 2005 Mar; 149(3):464-73. PubMed ID: 15864235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ezetimibe alone and in combination lowers the concentration of small, dense low-density lipoproteins in type 2 diabetes mellitus.
    Winkler K; Jacob S; Müller-Schewe T; Hoffmann MM; Konrad T
    Atherosclerosis; 2012 Jan; 220(1):189-93. PubMed ID: 22115011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of coadministration of ezetimibe and simvastatin in adolescents with heterozygous familial hypercholesterolemia.
    van der Graaf A; Cuffie-Jackson C; Vissers MN; Trip MD; Gagné C; Shi G; Veltri E; Avis HJ; Kastelein JJ
    J Am Coll Cardiol; 2008 Oct; 52(17):1421-9. PubMed ID: 18940534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. At sea with SEAS: the first clinical endpoint trial for ezetimibe, treatment of patients with mild to moderate aortic stenosis, ends with mixed results and more controversy.
    Hamilton-Craig I; Kostner K; Colquhoun D; Woodhouse S
    Heart Lung Circ; 2009 Oct; 18(5):343-6. PubMed ID: 19586799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of cholesterol uptake inhibition added to statin therapy among subjects following a low-carbohydrate diet: a randomized controlled trial.
    Chirinos JA; Williams MM; Bregman DB; Ashfaq H; Khayyam U; Iqbal N
    Am Heart J; 2010 May; 159(5):918.e1-6. PubMed ID: 20435205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.
    Guyton JR; Brown BG; Fazio S; Polis A; Tomassini JE; Tershakovec AM
    J Am Coll Cardiol; 2008 Apr; 51(16):1564-72. PubMed ID: 18420099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ezetimibe-Simvastatin, a pharmacodynamic interaction?
    Lozano R; Marin R; Santacruz MJ; Freire I
    Expert Opin Pharmacother; 2013 Feb; 14(3):359-60. PubMed ID: 23346887
    [No Abstract]   [Full Text] [Related]  

  • 17. Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans.
    Landmesser U; Bahlmann F; Mueller M; Spiekermann S; Kirchhoff N; Schulz S; Manes C; Fischer D; de Groot K; Fliser D; Fauler G; März W; Drexler H
    Circulation; 2005 May; 111(18):2356-63. PubMed ID: 15867181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment with high-dose statin, but not low-dose statin, ezetimibe, or the combination of low-dose statin and ezetimibe, limits infarct size in the rat.
    Birnbaum Y; Lin Y; Ye Y; Merla R; Perez-Polo JR; Uretsky BF
    J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):72-9. PubMed ID: 18287593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.
    Bays HE; Ose L; Fraser N; Tribble DL; Quinto K; Reyes R; Johnson-Levonas AO; Sapre A; Donahue SR;
    Clin Ther; 2004 Nov; 26(11):1758-73. PubMed ID: 15639688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term treatment with ezetimibe, simvastatin or their combination does not alter circulating adiponectin, resistin or leptin levels in healthy men.
    Gouni-Berthold I; Berthold HK; Chamberland JP; Krone W; Mantzoros CS
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):536-41. PubMed ID: 17973945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.